ID   HEM6_HUMAN              Reviewed;         454 AA.
AC   P36551; A8K275; B4DSD5; Q14060; Q53F08; Q8IZ45; Q96AF3;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2005, sequence version 3.
DT   15-MAR-2017, entry version 178.
DE   RecName: Full=Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial;
DE            Short=COX;
DE            Short=Coprogen oxidase;
DE            Short=Coproporphyrinogenase;
DE            EC=1.3.3.3;
DE   Flags: Precursor;
GN   Name=CPOX; Synonyms=CPO, CPX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=7987309; DOI=10.1093/hmg/3.8.1325;
RA   Delfau-Larue M.H., Martasek P., Grandchamp B.;
RT   "Coproporphyrinogen oxidase: gene organization and description of a
RT   mutation leading to exon 6 skipping.";
RL   Hum. Mol. Genet. 3:1325-1330(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ILE-294.
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ILE-294.
RC   TISSUE=Brain, Placenta, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 73-454 (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=8286403; DOI=10.1016/0005-2728(94)90083-3;
RA   Taketani S., Kohno H., Furukawa T., Yoshinaga T., Tokunaga R.;
RT   "Molecular cloning, sequencing and expression of cDNA encoding human
RT   coproporphyrinogen oxidase.";
RL   Biochim. Biophys. Acta 1183:547-549(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 101-454 (ISOFORM 1), AND VARIANT
RP   HIS-272.
RC   TISSUE=Foreskin;
RX   PubMed=8159699; DOI=10.1073/pnas.91.8.3024;
RA   Martasek P., Camadro J.-M., Delfau-Larue M.H., Dumas J.B.,
RA   Montagne J.J., de Verneuil H., Labbe P., Grandchamp B.;
RT   "Molecular cloning, sequencing, and functional expression of a cDNA
RT   encoding human coproporphyrinogen oxidase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:3024-3028(1994).
RN   [8]
RP   PROTEOLYTIC PROCESSING.
RX   PubMed=12862310; DOI=10.1620/tjem.200.39;
RA   Susa S., Daimon M., Ono H., Li S., Yoshida T., Kato T.;
RT   "The long, but not the short, presequence of human coproporphyrinogen
RT   oxidase is essential for its import and sorting to mitochondria.";
RL   Tohoku J. Exp. Med. 200:39-45(2003).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.58 ANGSTROMS) OF 111-453 IN COMPLEX WITH
RP   CITRATE, MUTAGENESIS OF 392-TYR--LEU-418, ACTIVE SITE, AND SUBUNIT.
RX   PubMed=16176984; DOI=10.1073/pnas.0506557102;
RA   Lee D.-S., Flachsova E., Bodnarova M., Demeler B., Martasek P.,
RA   Raman C.S.;
RT   "Structural basis of hereditary coproporphyria.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:14232-14237(2005).
RN   [14]
RP   VARIANT HCP TRP-331.
RX   PubMed=8012360; DOI=10.1093/hmg/3.3.477;
RA   Martasek P., Nordmann Y., Grandchamp B.;
RT   "Homozygous hereditary coproporphyria caused by an arginine to
RT   tryptophane substitution in coproporphyrinogen oxidase and common
RT   intragenic polymorphisms.";
RL   Hum. Mol. Genet. 3:477-480(1994).
RN   [15]
RP   VARIANT HCP SER-189, AND VARIANTS HIS-272 AND ILE-294.
RX   PubMed=7849704; DOI=10.1093/hmg/3.10.1807;
RA   Fujita H., Kondo M., Taketani S., Nomura N., Furuyama K., Akagi R.,
RA   Nagai T., Terajima M., Galbraith R.A., Sassa S.;
RT   "Characterization and expression of cDNA encoding coproporphyrinogen
RT   oxidase from a patient with hereditary coproporphyria.";
RL   Hum. Mol. Genet. 3:1807-1810(1994).
RN   [16]
RP   VARIANT HCP GLU-404.
RX   PubMed=7757079; DOI=10.1093/hmg/4.2.275;
RA   Lamoril J., Martasek P., Deybach J.-C., da Silva V., Grandchamp B.,
RA   Nordmann Y.;
RT   "A molecular defect in coproporphyrinogen oxidase gene causing
RT   harderoporphyria, a variant form of hereditary coproporphyria.";
RL   Hum. Mol. Genet. 4:275-278(1995).
RN   [17]
RP   VARIANT HCP ARG-280.
RX   PubMed=9048920; DOI=10.1007/s004390050338;
RA   Daimon M., Gojyou E., Sugawara M., Yamatani K., Tominaga M.,
RA   Sasaki H.;
RT   "A novel missense mutation in exon 4 of the human coproporphyrinogen
RT   oxidase gene in two patients with hereditary coproporphyria.";
RL   Hum. Genet. 99:199-201(1997).
RN   [18]
RP   VARIANTS HCP 162-GLN--ALA-168 DEL AND ASP-295.
RX   PubMed=8990017;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:1<78::AID-HUMU17>3.3.CO;2-B;
RA   Lamoril J., Deybach J.-C., Puy H., Grandchamp B., Nordmann Y.;
RT   "Three novel mutations in the coproporphyrinogen oxidase gene.";
RL   Hum. Mutat. 9:78-80(1997).
RN   [19]
RP   VARIANTS HCP LYS-201 AND SER-249.
RX   PubMed=9298818;
RX   DOI=10.1002/(SICI)1098-1004(1997)10:3<196::AID-HUMU3>3.3.CO;2-E;
RA   Schreiber W.E., Zhang X., Senz J., Jamani A.;
RT   "Hereditary coproporphyria: exon screening by heteroduplex analysis
RT   detects three novel mutations in the coproporphyrinogen oxidase
RT   gene.";
RL   Hum. Mutat. 10:196-200(1997).
RN   [20]
RP   VARIANTS HCP TRP-197; GLY-390 DEL AND ARG-427.
RX   PubMed=9888388;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:1<44::AID-HUMU5>3.0.CO;2-Q;
RA   Rosipal R., Lamoril J., Puy H., da Silva V., Gouya L.,
RA   de Rooij F.W.M., Te Velde K., Nordmann Y., Martasek P., Deybach J.-C.;
RT   "Systematic analysis of coproporphyrinogen oxidase gene defects in
RT   hereditary coproporphyria and mutation update.";
RL   Hum. Mutat. 13:44-53(1999).
RN   [21]
RP   VARIANTS HCP PHE-208; CYS-328; TRP-331 AND CYS-447.
RX   PubMed=12181641; DOI=10.1007/s100380200059;
RA   Wiman A., Floderus Y., Harper P.;
RT   "Two novel mutations and coexistence of the 991C>T and the 1339C>T
RT   mutation on a single allele in the coproporphyrinogen oxidase gene in
RT   Swedish patients with hereditary coproporphyria.";
RL   J. Hum. Genet. 47:407-412(2002).
RN   [22]
RP   VARIANTS HCP ALA-135; ARG-214 AND ARG-249.
RX   PubMed=15896662; DOI=10.1016/j.ymgme.2004.12.012;
RA   To-Figueras J., Badenas C., Enriquez M.T., Segura S., Alvarez C.,
RA   Mila M., Lecha M., Herrero C.;
RT   "Biochemical and genetic characterization of four cases of hereditary
RT   coproporphyria in Spain.";
RL   Mol. Genet. Metab. 85:160-163(2005).
RN   [23]
RP   VARIANT HCP ARG-279.
RX   PubMed=16398658; DOI=10.1111/j.1365-2141.2005.05852.x;
RA   Akagi R., Inoue R., Muranaka S., Tahara T., Taketani S.,
RA   Anderson K.E., Phillips J.D., Sassa S.;
RT   "Dual gene defects involving delta-aminolaevulinate dehydratase and
RT   coproporphyrinogen oxidase in a porphyria patient.";
RL   Br. J. Haematol. 132:237-243(2006).
RN   [24]
RP   ERRATUM.
RA   Akagi R., Inoue R., Muranaka S., Tahara T., Taketani S.,
RA   Anderson K.E., Phillips J.D., Sassa S.;
RL   Br. J. Haematol. 132:662-662(2006).
CC   -!- FUNCTION: Involved in the heme biosynthesis. Catalyzes the aerobic
CC       oxidative decarboxylation of propionate groups of rings A and B of
CC       coproporphyrinogen-III to yield the vinyl groups in
CC       protoporphyrinogen-IX.
CC   -!- CATALYTIC ACTIVITY: Coproporphyrinogen-III + O(2) + 2 H(+) =
CC       protoporphyrinogen-IX + 2 CO(2) + 2 H(2)O.
CC   -!- PATHWAY: Porphyrin-containing compound metabolism; protoporphyrin-
CC       IX biosynthesis; protoporphyrinogen-IX from coproporphyrinogen-III
CC       (O2 route): step 1/1.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:16176984}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion intermembrane space.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P36551-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P36551-2; Sequence=VSP_057182, VSP_057183;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Hereditary coproporphyria (HCP) [MIM:121300]: A form of
CC       porphyria. Porphyrias are inherited defects in the biosynthesis of
CC       heme, resulting in the accumulation and increased excretion of
CC       porphyrins or porphyrin precursors. They are classified as
CC       erythropoietic or hepatic, depending on whether the enzyme
CC       deficiency occurs in red blood cells or in the liver. Hereditary
CC       coproporphyria is an acute hepatic porphyria characterized by skin
CC       photosensitivity, attacks of abdominal pain, neurological
CC       disturbances, and psychiatric symptoms. Most attacks are
CC       precipitated by drugs, alcohol, caloric deprivation, infections,
CC       or endocrine factors. Hereditary coproporphyria is biochemically
CC       characterized by overexcretion of coproporphyrin III in the urine
CC       and in the feces. {ECO:0000269|PubMed:12181641,
CC       ECO:0000269|PubMed:15896662, ECO:0000269|PubMed:16398658,
CC       ECO:0000269|PubMed:7757079, ECO:0000269|PubMed:7849704,
CC       ECO:0000269|PubMed:8012360, ECO:0000269|PubMed:8990017,
CC       ECO:0000269|PubMed:9048920, ECO:0000269|PubMed:9298818,
CC       ECO:0000269|PubMed:9888388}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the aerobic coproporphyrinogen-III oxidase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA04033.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z34531; CAA84292.1; -; Genomic_DNA.
DR   EMBL; Z34803; CAA84292.1; JOINED; Genomic_DNA.
DR   EMBL; Z34804; CAA84292.1; JOINED; Genomic_DNA.
DR   EMBL; Z34805; CAA84292.1; JOINED; Genomic_DNA.
DR   EMBL; Z34806; CAA84292.1; JOINED; Genomic_DNA.
DR   EMBL; Z34807; CAA84292.1; JOINED; Genomic_DNA.
DR   EMBL; Z34808; CAA84292.1; JOINED; Genomic_DNA.
DR   EMBL; AK290140; BAF82829.1; -; mRNA.
DR   EMBL; AK299692; BAG61597.1; -; mRNA.
DR   EMBL; AK223481; BAD97201.1; -; mRNA.
DR   EMBL; CH471052; EAW79854.1; -; Genomic_DNA.
DR   EMBL; BC017210; AAH17210.1; -; mRNA.
DR   EMBL; BC023551; AAH23551.1; -; mRNA.
DR   EMBL; BC023554; AAH23554.1; -; mRNA.
DR   EMBL; D16611; BAA04033.1; ALT_INIT; mRNA.
DR   EMBL; Z28409; CAA82250.1; -; mRNA.
DR   CCDS; CCDS2932.1; -. [P36551-1]
DR   PIR; I52444; I52444.
DR   RefSeq; NP_000088.3; NM_000097.5. [P36551-1]
DR   UniGene; Hs.476982; -.
DR   PDB; 2AEX; X-ray; 1.58 A; A=111-454.
DR   PDBsum; 2AEX; -.
DR   ProteinModelPortal; P36551; -.
DR   SMR; P36551; -.
DR   BioGrid; 107763; 10.
DR   IntAct; P36551; 15.
DR   STRING; 9606.ENSP00000264193; -.
DR   ChEMBL; CHEMBL1681618; -.
DR   iPTMnet; P36551; -.
DR   PhosphoSitePlus; P36551; -.
DR   SwissPalm; P36551; -.
DR   BioMuta; CPOX; -.
DR   DMDM; 67476671; -.
DR   EPD; P36551; -.
DR   MaxQB; P36551; -.
DR   PaxDb; P36551; -.
DR   PeptideAtlas; P36551; -.
DR   PRIDE; P36551; -.
DR   Ensembl; ENST00000264193; ENSP00000264193; ENSG00000080819. [P36551-1]
DR   GeneID; 1371; -.
DR   KEGG; hsa:1371; -.
DR   UCSC; uc003dsx.4; human. [P36551-1]
DR   CTD; 1371; -.
DR   DisGeNET; 1371; -.
DR   GeneCards; CPOX; -.
DR   GeneReviews; CPOX; -.
DR   HGNC; HGNC:2321; CPOX.
DR   HPA; HPA015736; -.
DR   HPA; HPA054448; -.
DR   MalaCards; CPOX; -.
DR   MIM; 121300; phenotype.
DR   MIM; 612732; gene.
DR   neXtProt; NX_P36551; -.
DR   OpenTargets; ENSG00000080819; -.
DR   Orphanet; 79273; Hereditary coproporphyria.
DR   PharmGKB; PA134979958; -.
DR   eggNOG; KOG1518; Eukaryota.
DR   eggNOG; COG0408; LUCA.
DR   GeneTree; ENSGT00390000017311; -.
DR   HOGENOM; HOG000262768; -.
DR   HOVERGEN; HBG051897; -.
DR   InParanoid; P36551; -.
DR   KO; K00228; -.
DR   OMA; MELLIME; -.
DR   OrthoDB; EOG091G06ZF; -.
DR   PhylomeDB; P36551; -.
DR   TreeFam; TF300703; -.
DR   BioCyc; MetaCyc:HS01369-MONOMER; -.
DR   BRENDA; 1.3.3.3; 2681.
DR   Reactome; R-HSA-189451; Heme biosynthesis.
DR   UniPathway; UPA00251; UER00322.
DR   EvolutionaryTrace; P36551; -.
DR   GeneWiki; Coproporphyrinogen_III_oxidase; -.
DR   GenomeRNAi; 1371; -.
DR   PRO; PR:P36551; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000080819; -.
DR   CleanEx; HS_CPO; -.
DR   CleanEx; HS_CPOX; -.
DR   ExpressionAtlas; P36551; baseline and differential.
DR   Genevisible; P36551; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:Ensembl.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0004109; F:coproporphyrinogen oxidase activity; TAS:Reactome.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0005212; F:structural constituent of eye lens; IEA:Ensembl.
DR   GO; GO:0006783; P:heme biosynthetic process; TAS:Reactome.
DR   GO; GO:0006782; P:protoporphyrinogen IX biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0046685; P:response to arsenic-containing substance; IEA:Ensembl.
DR   GO; GO:0017085; P:response to insecticide; IEA:Ensembl.
DR   GO; GO:0010039; P:response to iron ion; IEA:Ensembl.
DR   GO; GO:0010288; P:response to lead ion; IEA:Ensembl.
DR   GO; GO:0051597; P:response to methylmercury; IEA:Ensembl.
DR   Gene3D; 3.40.1500.10; -; 1.
DR   InterPro; IPR001260; Coprogen_oxidase_aer.
DR   InterPro; IPR018375; Coprogen_oxidase_CS.
DR   PANTHER; PTHR10755; PTHR10755; 1.
DR   Pfam; PF01218; Coprogen_oxidas; 1.
DR   PRINTS; PR00073; COPRGNOXDASE.
DR   SUPFAM; SSF102886; SSF102886; 1.
DR   PROSITE; PS01021; COPROGEN_OXIDASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; Heme biosynthesis; Mitochondrion; Oxidoreductase;
KW   Phosphoprotein; Polymorphism; Porphyrin biosynthesis;
KW   Reference proteome; Transit peptide.
FT   TRANSIT       1    110       Mitochondrion. {ECO:0000250}.
FT   CHAIN       111    454       Oxygen-dependent coproporphyrinogen-III
FT                                oxidase, mitochondrial.
FT                                /FTId=PRO_0000006029.
FT   REGION      193    202       Important for dimerization.
FT                                {ECO:0000305}.
FT   REGION      260    262       Substrate binding.
FT   REGION      392    428       Important for dimerization.
FT   REGION      411    413       Substrate binding.
FT   ACT_SITE    258    258       Proton donor.
FT                                {ECO:0000269|PubMed:16176984}.
FT   BINDING     244    244       Substrate. {ECO:0000305}.
FT   SITE        327    327       Important for dimerization.
FT   MOD_RES     112    112       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3B7D0}.
FT   MOD_RES     404    404       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P36552}.
FT   MOD_RES     404    404       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P36552}.
FT   VAR_SEQ     272    287       NKQWWFGGGCDLTPTY -> KGLRSYGKYCRAKCAF (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057182.
FT   VAR_SEQ     288    454       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057183.
FT   VARIANT     135    135       V -> A (in HCP; dbSNP:rs201826432).
FT                                {ECO:0000269|PubMed:15896662}.
FT                                /FTId=VAR_023444.
FT   VARIANT     162    168       Missing (in HCP).
FT                                {ECO:0000269|PubMed:8990017}.
FT                                /FTId=VAR_002151.
FT   VARIANT     189    189       G -> S (in HCP; <5% of activity;
FT                                dbSNP:rs759347283).
FT                                {ECO:0000269|PubMed:7849704}.
FT                                /FTId=VAR_002152.
FT   VARIANT     197    197       G -> W (in HCP).
FT                                {ECO:0000269|PubMed:9888388}.
FT                                /FTId=VAR_002153.
FT   VARIANT     201    201       E -> K (in HCP).
FT                                {ECO:0000269|PubMed:9298818}.
FT                                /FTId=VAR_002154.
FT   VARIANT     208    208       S -> F (in HCP; dbSNP:rs28929486).
FT                                {ECO:0000269|PubMed:12181641}.
FT                                /FTId=VAR_019067.
FT   VARIANT     214    214       L -> R (in HCP).
FT                                {ECO:0000269|PubMed:15896662}.
FT                                /FTId=VAR_023445.
FT   VARIANT     249    249       P -> R (in HCP).
FT                                {ECO:0000269|PubMed:15896662}.
FT                                /FTId=VAR_023446.
FT   VARIANT     249    249       P -> S (in HCP).
FT                                {ECO:0000269|PubMed:9298818}.
FT                                /FTId=VAR_002155.
FT   VARIANT     272    272       N -> H (in dbSNP:rs1131857).
FT                                {ECO:0000269|PubMed:7849704,
FT                                ECO:0000269|PubMed:8159699}.
FT                                /FTId=VAR_002156.
FT   VARIANT     279    279       G -> R (in HCP; a patient carrying also
FT                                the L-12 mutation in ALAD;
FT                                dbSNP:rs121917874).
FT                                {ECO:0000269|PubMed:16398658}.
FT                                /FTId=VAR_058005.
FT   VARIANT     280    280       G -> R (in HCP).
FT                                {ECO:0000269|PubMed:9048920}.
FT                                /FTId=VAR_002157.
FT   VARIANT     294    294       V -> I (in dbSNP:rs2228056).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:7849704,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_002158.
FT   VARIANT     295    295       H -> D (in HCP; dbSNP:rs121917870).
FT                                {ECO:0000269|PubMed:8990017}.
FT                                /FTId=VAR_002159.
FT   VARIANT     328    328       R -> C (in HCP; dbSNP:rs28929487).
FT                                {ECO:0000269|PubMed:12181641}.
FT                                /FTId=VAR_019068.
FT   VARIANT     331    331       R -> W (in HCP; dbSNP:rs121917866).
FT                                {ECO:0000269|PubMed:12181641,
FT                                ECO:0000269|PubMed:8012360}.
FT                                /FTId=VAR_002160.
FT   VARIANT     352    352       R -> C (in dbSNP:rs11921054).
FT                                /FTId=VAR_048827.
FT   VARIANT     390    390       Missing (in HCP).
FT                                {ECO:0000269|PubMed:9888388}.
FT                                /FTId=VAR_002161.
FT   VARIANT     404    404       K -> E (in HCP; harderoporphyria form;
FT                                dbSNP:rs121917868).
FT                                {ECO:0000269|PubMed:7757079}.
FT                                /FTId=VAR_002162.
FT   VARIANT     427    427       W -> R (in HCP).
FT                                {ECO:0000269|PubMed:9888388}.
FT                                /FTId=VAR_002163.
FT   VARIANT     447    447       R -> C (in HCP; dbSNP:rs28931603).
FT                                {ECO:0000269|PubMed:12181641}.
FT                                /FTId=VAR_019069.
FT   MUTAGEN     392    418       Missing: Loss for dimerization.
FT                                {ECO:0000269|PubMed:16176984}.
FT   CONFLICT    247    247       I -> T (in Ref. 7; CAA82250).
FT                                {ECO:0000305}.
FT   HELIX       122    128       {ECO:0000244|PDB:2AEX}.
FT   STRAND      130    132       {ECO:0000244|PDB:2AEX}.
FT   HELIX       138    143       {ECO:0000244|PDB:2AEX}.
FT   HELIX       148    170       {ECO:0000244|PDB:2AEX}.
FT   STRAND      177    183       {ECO:0000244|PDB:2AEX}.
FT   TURN        184    186       {ECO:0000244|PDB:2AEX}.
FT   STRAND      187    196       {ECO:0000244|PDB:2AEX}.
FT   STRAND      198    213       {ECO:0000244|PDB:2AEX}.
FT   HELIX       216    224       {ECO:0000244|PDB:2AEX}.
FT   STRAND      237    251       {ECO:0000244|PDB:2AEX}.
FT   STRAND      256    267       {ECO:0000244|PDB:2AEX}.
FT   STRAND      273    284       {ECO:0000244|PDB:2AEX}.
FT   HELIX       290    305       {ECO:0000244|PDB:2AEX}.
FT   HELIX       311    322       {ECO:0000244|PDB:2AEX}.
FT   HELIX       326    328       {ECO:0000244|PDB:2AEX}.
FT   STRAND      330    342       {ECO:0000244|PDB:2AEX}.
FT   HELIX       347    359       {ECO:0000244|PDB:2AEX}.
FT   HELIX       361    372       {ECO:0000244|PDB:2AEX}.
FT   HELIX       379    399       {ECO:0000244|PDB:2AEX}.
FT   HELIX       406    408       {ECO:0000244|PDB:2AEX}.
FT   STRAND      409    411       {ECO:0000244|PDB:2AEX}.
FT   HELIX       414    420       {ECO:0000244|PDB:2AEX}.
FT   HELIX       438    447       {ECO:0000244|PDB:2AEX}.
SQ   SEQUENCE   454 AA;  50152 MW;  6EC3D15FD8FD86B5 CRC64;
     MALQLGRLSS GPCWLVARGG CGGPRAWSQC GGGGLRAWSQ RSAAGRVCRP PGPAGTEQSR
     GLGHGSTSRG GPWVGTGLAA ALAGLVGLAT AAFGHVQRAE MLPKTSGTRA TSLGRPEEEE
     DELAHRCSSF MAPPVTDLGE LRRRPGDMKT KMELLILETQ AQVCQALAQV DGGANFSVDR
     WERKEGGGGI SCVLQDGCVF EKAGVSISVV HGNLSEEAAK QMRSRGKVLK TKDGKLPFCA
     MGVSSVIHPK NPHAPTIHFN YRYFEVEEAD GNKQWWFGGG CDLTPTYLNQ EDAVHFHRTL
     KEACDQHGPD LYPKFKKWCD DYFFIAHRGE RRGIGGIFFD DLDSPSKEEV FRFVQSCARA
     VVPSYIPLVK KHCDDSFTPQ EKLWQQLRRG RYVEFNLLYD RGTKFGLFTP GSRIESILMS
     LPLTARWEYM HSPSENSKEA EILEVLRHPR DWVR
//
